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Inverse correlation between IL-7 receptor expression
and CD8 T cell exhaustion during persistent antigen
stimulation
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Max Lhning, Tobias Junt, Hans Christian Probst, Hans Hengartner and
Rolf M. Zinkernagel
Institute of Experimental Immunology, Zurich, Switzerland
Persistence is a hallmark of infection by viruses such as HIV, hepatitis B virus, hepatitis C
virus and LCMV. In the case of LCMV, persistence may often be associated with
exhaustion of CD8+ Tcells. We demonstrate here that persistent antigen suppressed IL-
7Ra expression and this correlated with Tcell exhaustion and reduced expression of the
anti-apoptotic molecule B cell leukemia/lymphoma 2 (Bcl-2). In contrast, exposure to
short-lived antigen only temporarily suppressed IL-7Ra expression, failed to induce T
cell exhaustion, and primed Tcells. Persistent antigen also suppressed IL-7Ra expression
on primed Tcells and this correlated with exhaustion of a previously stable primed Tcell
population. These findings suggest that antigen longevity regulates T cell fate.
Supporting Information for this article is available at http://www.wiley-
vch.de/contents/jc_2040/2005/25828_s.pdf or from the author
Introduction
Infection with viruses that are prone to persist can result
in different outcomes. Firstly, in some circumstances
complete elimination of the virus is possible, and this is
normally associated with increased numbers of stable
and “quiescent” memory CD8+ Tcells [1]. Secondly, the
infection may be largely controlled to low levels,
resulting in a state of immune memory involving
maintenance of a small number of effector CD8+ T
cells [2–4]. This immune surveillance may be stable or,
alternatively, fade over-time, allowing re-emergence of
the virus [5]. Lastly, infection is initially not controlled,
allowing the systemic persistence of the virus at
sufficiently high levels to cause exhaustion of the
virus-specific CD8+ T cell population [3, 4, 6].
Exhaustion is preceded by a temporary phase when
CD8+ T cells lack lytic mediators such as granzyme B or
perforin and exhibit additional functional impairment
[7], followed by the eventual physical deletion of virus-
specific T cells.
LCMV is a poorly cytopathic RNA-virus which,
depending on the strain of the virus and the immune
system of the infected host, can model all the
possibilities discussed above. Infections by the rapidly
replicating LCMV-Docile or LCMV-Clone13 strains
usually cause early CTL exhaustion, with those few
remaining cells being unable to produce IFN-c or
mediate cytotoxicity [8]. In contrast, LCMV-WE and
LCMV-Armstrong, which both have a weaker replication
capacity, are rapidly cleared in immune-competent mice
largely as a result of efficient CD8+ T cells. LCMV-WE
infection of MHC class II deficient mice is initially
controlled; however, virus re-emerges after 50–150 days
despite a pre-existing initially functional memory CD8+
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T cell population [5]. These observations indicate that
the distinct results of CD8+ T cell induction and
maintenance versus exhaustion closely correlate with
virus clearance or persistence. A similar relationship has
also been demonstrated for non-viral antigens [9–11].
IL-7 is required for the maintenance of naive and
memory CD8+ T cells [12], probably as a result of its
ability to mediate activation of STAT5 and up-regulation
of the anti-apoptotic molecule B cell leukemia/lympho-
ma 2 (Bcl-2) [13, 14]. A recent study demonstrated that
following LCMV infection, a distinct population of CD8+
Tcells does not express IL-7Ra (CD127) [15]. These cells
exhibit effector function but have a short half-life,
whereas CD8+ T cells expressing high levels of IL-7Ra
survive for a long period partly due to high expression of
Bcl-2. Here we analyzed the role of IL-7Ra expression on
CD8+ T cells during persistent or short-term antigen
exposure.
Results
Viral persistence suppresses IL-7Ra expression
and diminishes the CD8+ T cell response
During infection with a high dose (2106 PFU) of
LCMV-Docile, the virus cannot be controlled initially and
persists [6]. LCMV-specific CD8+ T cells are initially
primed; however, they lose their function during early
infection and have a short lifespan [6, 8]. IL-7 appears to
be particularly important for the survival of antigen-
experienced CD8+ Tcells, since expression of the IL-7Ra
on the cell surface was found on long-lived “quiescent”
or central memory cells but not on short-lived effector
CD8+ T cells [15, 16].
To investigate the expression of IL-7Ra during the
establishment of a persisting viral infection, we infected
C57BL/6 mice with 2106 PFU of LCMV-Docile or
LCMV-WE. As described earlier, infection with
2106 PFU LCMV-Docile led to virus persistence,
whereas infection with 2106 PFU LCMV-WE led to
viral clearance (Fig. 1A). After infection with LCMV-WE,
T cells specific for the dominant MHC class I-restricted
LCMV peptide gp33 (glycoprotein33–41; KAVYNFATC)
were detected by staining with a tetramer–gp33 (tet-
gp33) reagent and contained an IL-7Rahi population,
which is probably responsible for building the memory
pool [15]. After infection with 2106 PFU LCMV-Docile,
tet-gp33+CD8+ T cells were also detectable. However,
none of these specific T cells expressed IL-7Ra (Fig. 1B).
We analyzed the ability of these T cells to produce
IFN-c after in vitro re-stimulation for 6 h. The gp-33-
specific T cells from mice infected with LCMV-WE were
able to produce IFN-c, whereas LCMV-Docile infection
led to a functional anergy of specific CD8+ Tcells. LCMV
nucleoprotein (NP) is available longer after LCMV
Fig. 1.Viral persistence suppressed IL-
7Ra expression and diminished cell
survival. Naive mice were infected
with 2106 PFU LCMV-WE or -Docile.
(A) At day 16 post-infection viral titers
were determined in spleens by a
plaque assay. (B) At the same time-
point CD8+ T cells were analyzed for
binding to tet-gp33 and tet-np396, and
for IL-7Ra expression (gated on CD8+
cells, n=4–5). Splenocyteswere also re-
stimulated in vitro with gp33 (lower
left panel) or np396 (lower right panel)
and analyzed for the ability to produce
IFN-c. (C) LCMV-memory mice
(50 days post-infection with 200 PFU
LCMV-WE) were challenged with
2106 PFU LCMV-Docile. Splenocytes
were analyzed 16 days later for virus
spleen titers and tet-gp33+CD8+ T cells
as well as IL-7Ra expression.
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infection [17] and therefore NP-specific T cells are
believed to be more susceptible to T cell exhaustion [17,
18]. As shown in Fig. 1B, tet-np396+CD8+ T cells (i.e.
specific for NP epitope 396–404) were absent after an
infection with LCMV-Docile (persistent infection),
whereas infection with 200 PFU LCMV-WE (non-
persistent infection) led to a high frequency of
functional np396-specific CD8+ T cells (data not shown
and [17]).
Persistence of antigen or, alternatively, an LCMV-
Docile-specific trait could potentially be responsible for
the observed down-regulation of IL-7Ra. Therefore,
mice that had been infected 50 days previously with
LCMV-WE (200 PFU) were then challenged with
2106 PFU LCMV-Docile (memory-CTL challenge).
These mice cleared LCMV from spleen by day 16 post-
challenge (Fig. 1C) and most tet-gp33+CD8+ T cells
expressed IL-7Ra (Fig. 1C). This indicated that antigen
persistence itself regulated IL-7Ra expression on specific
CD8+ T cells.
Prolonged down-regulation of the IL-7Ra on
responding CD8+ T cells by persistent antigen
Despite antigen persistence, many other factors could
lead to suppression of IL-7Ra expression during
infection with LCMV. Cytokine profiles differ signifi-
cantly after infection with different virus strains (K. S.
Lang, unpublished) and they have been demonstrated to
influence IL-7Ra expression. To avoid such differences
and to directly evaluate the impact of antigen persis-
tence, we treated mice with peptides via the i.p. route
using 1 mg gp33 delivered in PBS or IFA. Peptide in PBS
was functionally short lived in vivo (see Supporting
Information, Supplementary Fig. A). In contrast, pep-
tide in IFA functionally persisted for at least one week in
vivo (Supplementary Fig. A), which is consistent with
published observations [9].
We transferred splenocytes from LCMV-gp33–H-2Db-
specific TCR-transgenic mice (P14) [19] into naive
C57BL/6 recipients and treated them with 1 mg gp33 in
PBS, or with various doses (1.0 and 0.1 mg) of gp33 in
IFA.Mice receiving gp33 in PBS (days 0 and 3) exhibited
elevated frequencies of tet-gp33+CD8+ T cells in the
spleen (Fig. 2A). When gp33 was given in IFA (days 0
and 3), tet-gp33+ cells expanded until day 3 (similar to
tet-gp33+ cells, treated with gp33 in PBS; Fig. 2A and
Supplementary Fig. B); however, by day 12 tet-gp33+
cells could no longer be detected (Fig. 2A), and recipient
mice were no longer protected from a challenge LCMV
infection (Fig. 2D).
Analysis of IL-7Ra expression revealed that stimula-
tion with either persistent or non-persistent antigen
(given only on day 0) resulted initially in the rapid
down-regulation of IL-7Ra on all antigen-specific CD8+
Fig. 2. Permanent down-regulation of the IL-7Ra on responding
CD8+ T cells stimulated by persistent antigen. (A–D) P14
splenocytes were injected into naive C57BL/6 mice at day –1
(107 splenocytes per mouse with or without CFSE labeling). (A)
On day 0 and day 3 mice were treated with gp33 (1 mg or
0.1 mg) in IFA or 1 mg in PBS and splenocyteswere analyzed for
tetramer binding on days 0, 3 and 12 (n=3–6). (B) Mice were
immunizedwith 1 mg gp33 in PBS (black lines, black numbers)
or IFA (grey lines, grey numbers) on day 0 and expression of IL-
7Ra and IL-2Rb/IL-15Rb was analyzed on days 0, 2, 4, and 6.
Histogram plots show splenocytes gated on tet-gp33+CD8+ T
cells (n=3–5; IL-7Ra expression on day 4 and day 6: p<0.05).
FACS analysis of naive tet-gp33+CD8+ T cells (day 0) is shown as
black histogramplots (n=2–3). (C)Micewere treatedwith 0.1 mg
gp33 in IFA and on day 3 splenocytes were analyzed for IL-7Ra
and CFSE content (grey dots gated on tet-gp33–CD8+ T cells, red
dots gated on tet-gp33+CD8+ T cells, n=3). (D) Mice were
immunized as described in (A) and challenged with 200 PFU of
LCMV-WE on day 16. Virus titers in spleens were analyzed
4 days later. (E) Naive C57BL/6 mice were treated with 50 lg of
cytidine guanosine dinucleotide (CpG) together with 1 mg gp33
in PBS (black squares) or together with 1 mg gp33 in IFA (white
squares) given i.p. on days 0, 2 and 5, then boostedwith peptide
on day 9. The numbers of tet-gp33+ cells present in the blood
were determined by tetramer staining (n=6–7).
Karl S. Lang et al. Eur. J. Immunol. 2005. 35: 738–745740
f 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji.de
T cells (Fig. 2B, day 2) following the first rounds of
cellular divisions (Fig. 2C). All CD8+ T cells responding
to non-persistent antigen (gp33 in PBS) regained
expression of IL-7Ra (Fig. 2B, days 4–6) at a time-point
that correlated with the disappearance of antigen
(Supplementary Fig. A). In contrast, the large majority
of cells stimulated with persistent antigen failed to re-
express IL-7Ra (gp33 in IFA, Fig. 2B, days 4–6). Peptide
was still present at these time-points (Supplementary
Fig. A); therefore, it was likely that a constant
stimulation of the TCR was responsible for the
continued down-regulation of the IL-7Ra. Tet-
gp33+CD8+ T cells stimulated by either non-persistent
or persistent antigen up-regulated the b-chain of the
receptor for IL-2 and IL-15 (IL-2Rb/IL-15b, CD122), and
this increased expression was maintained for the
investigated period of 6 days (Fig. 2B). Thus, persistent
antigen reduced CD8+ T cell survival (also in a non-
transgenic system, Fig. 2E), which closely correlated
with reduced expression of the functional receptor for
the survival cytokine IL-7.
Enhanced apoptosis of CD8+ T cells with
down-regulated IL-7Ra
One mechanism by which IL-7Ra expression could
influence apoptosis and cellular survival would be
through regulation of the anti-apoptotic molecule Bcl-2
[20–22]. IL-7Ra-expressing cells are known to signal
through STAT5 and express high levels of Bcl-2 [15, 23],
an anti-apoptotic molecule demonstrated to play a
crucial role in cell survival [14]. Indeed, stimulation of
P14 splenocytes with gp33 in either IFA or PBS led to
down-regulation of Bcl-2 on day 3 (Fig. 3A), paralleled
by IL-7Ra down-regulation. By day 5, Bcl-2 was re-
expressed on tet-gp33+CD8+ Tcells in mice treated with
gp33 in PBS, whereas cells from mice treated with gp33
in IFA continued to express reduced levels Bcl-2
(Fig. 3A), correlating with limited IL-7Ra expression.
To determine whether IL-7Ra re-expression was indeed
crucial for cell survival, we stained splenocytes for
Annexin-V at day 5 after injection of mice with gp33 in
IFA. Tet-gp33+ splenocytes contained an increased
number of apoptotic cells within the fraction expressing
low levels of IL-7Ra (IL-7Ralo) as compared with the few
remaining cells expressing high levels of IL-7Ra (IL-
7Rahi, Fig. 3B).
In addition, we separated P14 splenocytes exposed to
persistent antigen in vivo (1 mg gp33 in IFA for 4 days)
into IL-7Ralo and IL-7Rahi populations (to 95% and 86%
purity of CD8+ T cells, respectively; Fig. 3C), labeled
each population with CFSE, then injected the labeled
cells into separate naive C57BL/6 hosts. The survival of
the tet-gp33+ population contained within the trans-
ferred population was then monitored by FACS. Shortly
before transfer, the IL-7Ralotet-gp33+CD8+ fraction
represented 0.22% of all transferred splenocytes,
whereas 0.27% of total splenocytes were IL-7Rahitet-
gp33+CD8+. Three days later, the IL-7Ralotet-
gp33+CD8+ fraction represented only 0.060.02% of
the total transferred population. In contrast, the IL-
7Rahitet-gp33+CD8+ fraction survived, now represent-
ing 0.250.05% of the total transferred cells (Fig. 3C).
Interestingly, those few CD8+ T cells that were initially
IL-7Ralo but that did survive following transfer were
Fig. 3. Enhanced apoptosis byCD8+T cellswith down-regulated
IL-7Ra. P14 splenocytes were injected into naive C57BL/6-mice
at day –1 (107 splenocytes per mouse) and at day 0 mice were
immunized with 1 mg gp33 in PBS or IFA. (A) On days 3 and 5
splenocytes were stained with anti-Bcl-2 antibody or with an
isotype control. Splenocytes from mice treated with 1 mg of
gp33 in PBS (black lines, black numbers) or in IFA (grey lines,
grey numbers) were gated on tet-gp33+CD8+ expression and for
large cell size (as blasts showed the biggest difference in Bcl-2
expression), then analyzed for expression of Bcl-2 (n=4–5, Bcl-2
expression on day 5; p<0.05). Naive tet-gp33–CD8+ T cells were
stained with anti-Bcl-2 (black histogram, naive) and with the
isotype control (grey histogram, naive). (B) On day 5 spleno-
cytes from mice treated with 1 mg of gp33 in IFAwere stained
for IL-7Ra and Annexin-V. The degree of apoptosis of IL-7Rahi
and IL-7Ralo is shown (ratio of Annexin+/Annexin– cells) for
splenocytes gated on tet-gp33+CD8+ T cells (n=4, *p<0.05). (C)
On day 4 splenocytes pooled from threemice treatedwith 1 mg
of gp33 in IFAwere sorted into IL-7Rahi and IL-7Ralo populations
byMACS and labeledwith CFSE. Each fractionwas injected into
a separate group of naive C57BL/6 mice (n=3). Dot plots show
CD8 and IL-7Ra expression on CFSE+ transferred cells (day 4,
shortly before transfer and day 7, 3 days after transfer). The bar
charts indicate tet-gp33+CD8+ T cells as a % of total transferred
splenocytes (p<0.05 between IL-7Rhi and IL-7Rlo on day 7). One
of two experiments is shown.
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found to have re-expressed higher levels of IL-7Ra
(Fig. 3C). These data suggested that IL-7Ra expression
was both directly and causally linked to the survival of
antigen-experienced CD8+ T cells.
Loss of IL-7Ra expression and continuously
diminished cell survival on memory CD8+ T cells
exposed to persistent antigen in vivo
To analyze the expression of IL-7Ra on memory CD8+ T
cells after antigen challenge we compared tet-
gp33+CD8+ T cells in LCMV-immune mice (200 PFU,
day 300 post-infection), or LCMV-immune mice which
had received 1 mg gp33 in PBS 2 days previously. As
observed for naive CD8+ T cells (Fig. 2B), peptide
stimulation of memory CD8+ Tcells resulted in the rapid
down-regulation of IL-7Ra expression (Fig. 4A). Those T
cells that had down-regulated IL-7Ra exhibited an
effector phenotype in that they also expressed granzyme
B, plus increased levels of CD27, CD43 and CD44
(Fig. 4A) [24], and a slight down-regulation of CD45RB.
Furthermore, peptide-treated splenocytes were able to
effectively lyse gp33-labeled target cells directly ex vivo
within 7 h (Fig. 4A).
These data indicate that administration of antigen
resulted in the rapid activation of memory CD8+ T cells
to exhibit full effector function but low IL-7Ra
expression. We hypothesized that exposure of memory
CD8+ T cells to persistent antigen may result in
continued IL-7Ra down-regulation, eventually resulting
in the loss of these cells. To address this question we
treated LCMV-immune mice (day 30 after LCMV-WE
infection) with gp33 in IFA, or as a control with IFA
alone, and then examined IL-7Ra expression, cellular
survival and CD8+ T cell function. Persistent antigen
resulted in the permanent down-regulation of IL-7Ra on
memory T cells, and the numbers of tet-gp33+ cells
continuously declined over time when compared with
IFA-treated controls (Fig. 4B).
Sixty days after the first peptide administration a
subset of mice were sacrificed and their splenocytes
analyzed for CD8+ T cell effector function. Memory
splenocytes from mice treated with gp33 in IFA did not
exhibit significant lytic capacity (Fig. 4B). Splenocytes
frommice treated with IFA alone were able to effectively
lyse targets after a 12- or 20-h incubation (Fig. 4B) [25].
We infected the remaining mice with a recombinant
vaccinia virus expressing the gp33 peptide (VV-gp33)
[17]. As expected, tet-gp33+CD8+ T cells from mice
treated with IFA alone expanded in both the spleen and
the peritoneum, whereas tet-gp33+CD8+ T cells of
gp33-IFA treated mice only showed minimal expansion
(Fig. 4B). Thus, persistent antigen exposure resulted in
continuous exhaustion/deletion even of “quiescent” or
central memory T cells.
Loss of IL-7Ra expression onmemory CD8+ T cells
preceded and predicted virus re-emergence
Our data implied that viral antigen that persists despite a
specific CD8+ T cell response may continuously delete
the memory Tcell population. Eventually this could lead
Fig. 4. Loss of IL-7Ra expression and diminished cell survival of
memory CD8+ T cells induced by persistent antigen. (A) Naive
C57BL/6micewere infectedwith LCMV-WE.Micewere injected
300 days later with 1 mg gp33 in PBS (grey line, n=3), or left
untreated (black line, n=2). Two days after peptide injection,
tet-gp33+CD8+ splenocytes were analyzed for expression of IL-
7Ra, intracellular granzyme B, CD27, CD43, CD44 and CD45RB.
Splenocytes were tested for the ability to lyse gp33-labeled
target cells directly ex vivo in a 7-h assay (n=2–3, right panel). (B)
C57BL/6 mice were infected with LCMV-WE, and 30 days after
infection mice were injected with IFA alone or 0.1 mg gp33 in
IFA at weekly intervals (see arrows). Numbers of tet-gp33+CD8+
T cells were analyzed in blood samples (n=6–7, upper left). On
days 36 and 76 CD8+ T cellswere analyzed for expression of tet-
gp33 and IL-7Ra (n=6–7) as indicated. At day 90 the ability of
splenocytes to lyse gp33-labeled target cells directly ex vivowas
determined by cytotoxicity assays (n=3). On day 110,micewere
challenged with VV-gp33 and 5 days later mice were analyzed
for numbers of tet-gp33+CD8+ T cells present in the spleen and
peritoneum.
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to a loss of CD8+ T cell memory below a certain
threshold that is required to successfully control residual
virus replication. The result would be virus re-emer-
gence, a hallmark of chronic virus infections. In the
LCMV model, a situation as described above is observed
in LCMV-infected MHC class II deficient mice
(MHC II–/–), where after an initial phase of CD8+ T
cell mediated immune control, re-emergence of viremia
is observed by day 50–150. We therefore followed IL-
7Ra expression over time in LCMV-infected MHC class II
deficient mice or C57BL/6 controls (Fig. 5). Whereas IL-
7Ra expression on tet-gp33+CD8+ Tcells remained high
after infection of C57BL/6mice (control), we observed a
continuous loss of IL-7Ra expression after infection of
MHC class II deficient mice, directly correlating with and
accurately predicting virus re-appearance.
Discussion
In summary, TCR stimulation by specific antigen
resulted in a rapid down-regulation of the a-chain of
the IL-7R in a comparable way on both naive and
memory CD8+ T cells. When antigen-induced TCR
stimulation was only available for a short period,
responsive T cells were able to re-express IL-7R. These
cells were apparently able to survive for extended
periods of time and to differentiate into “quiescent” or
central memory CD8+ T cells. In contrast, persistent
antigen prolonged IL-7Ra down-regulation and re-
sulted in deletion of antigen-specific naive or memory
T cells.
Transgenic expression of Bcl-2 restored T cell
numbers in mice that lacked IL-7 signaling, proving
that IL-7 signaling mediated protection from apoptosis
[22]. In addition to expression of anti-apoptotic bcl-2,
serine-protease inhibitors are critical determinants of
CD8+ T cell survival [26]. Over-expression of serine-
protease inhibitor 2A in CD8+ T cells led to an impaired
CD8+ Tcell contraction phase following LCMV infection,
whereas a lack of these enzymes was followed by
enhanced contraction. Lack of CD8+ T cell contraction
was similarly observed by analyzing virus-infected mice
which were deficient for the pro-apoptotic molecule Bim
[27]. A recent report demonstrated that loss of Bim
increased T cell production and function in IL-7R-
deficient mice [28].
It is noteworthy that additional factors than antigen
persistencemay influence the fate of virus-specific CD8+
T cells. In particular, T helper cells have been shown to
rescue memory CD8+ T cells from their ongoing
depletion [29]. In these experiments, persisting viral
antigen was experimentally excluded. Thus, the pre-
sence of T help represents another effective means to
keep CD8+ T cell memory stable. On the other hand,
persistent antigen in our model deleted CD8+memory T
cells even in the presence of CD4+ Tcells, demonstrating
that here bystander help might be inefficient in
sustaining IL-7Ra expression [29]. In addition, our data
identified loss of IL-7Ra expression on specific CD8+ T
cells as a marker that highlights memory T cell
exhaustion and virus re-appearance. Thus, IL-7R
expression on virus-specific T cells may serve as a
clinical marker to follow Tcell responses in chronic viral
diseases such as HIV or hepatitis C virus in man.
Materials and methods
Mice and viruses
LCMV strains were used as described previously [17]. VV-gp33
(2106 PFU) [17] was injected i.v. P14 mice [19], MHC II–/–
mice and C57BL/6-mice were bred locally and kept under
specific pathogen free conditions. Animal experiments were
performed in accordance with the Zrich, Switzerland, Swiss
animal protection law.
Peptides, adoptive transfer and virus titers
Peptide gp33 was dissolved in DMSO (10 mg/ml) and then
diluted in PBS. It was administered i.p. in PBS in a volume of
300 ll or in IFA (diluted 1:1 with IFA and administered i.p. in
Fig. 5. Loss of IL-7Ra expression on memory CD8+ T cells
precedes and predicts virus re-emergence. MHC II–/– and
C57BL/6 mice were infected with 200 PFU LCMV-WE. At the
indicated time-points, mice were analyzed for viral blood titer
and expression of IL-7Ra on tet-gp33+CD8+ T cells.
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300-ll volumes). For adoptive transfer experiments 107 P14
splenocytes were injected i.v. into naive C57BL/6 mice, which
were then immunized with peptide in PBS or IFA as described
above. Virus titers were measured by using a focus-forming
assay [17].
FACS analysis, cell sorting and cytotoxicity assays
Extracellular and intracellular stainings were performed as
described previously [17] or by following the manufacturers'
instructions. Antibodies used included anti-IL-7R antibody
(eBioscience), anti-CD8, anti-Bcl-2, anti-IFN-c and Annexin-V
(Pharmingen). Tetramers were made in-house as described
previously [17]. For labeling, P14 splenocytes were incubated
for 10 min with 5 lM CFSE (Molecular Probes). For cell
sorting, splenocytes were stained with allophycocyanin (APC)-
conjugated anti-IL-7RamAb, washed, and further labeled with
anti-APC microbeads (Miltenyi Biotec). IL-7Rahi and IL-7Ralo
cell fractions were separated as described previously [30]. For
cytotoxicity assays, 51Cr-release assays were performed as
described previously [17].
Statistical analysis
Data are expressed as the meanSEM; n=number of different
animals used for an experiment; * denotes a statistically
significant difference in a Student t-test (p<0.05).
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